ZENDAL is a business group of 7 companies focused on Biotechnology and it is engaged in the development, manufacturing, and marketing of Biological and Pharmaceutical products for both human and animal health. The company, founded in 1993, operates within the Biopharma, Biotechnology, Health Care, and Pharmaceutical industries. Its slogan "Biologicals and Vaccines for human and animal health" reflects its primary focus.
Zendal has positioned itself as a crucial player in disease prevention for both human and animal health utilizing Biotechnology. As the corporate brand of the group, it draws together seven companies dedicated to high added value products in the health sector: CZ Vaccines, Biofabri, Vetia, Petia vet health, Zinereo Pharma, Probisearch, and Bialactis.
The company's emphasis on Biotechnology underscores its potential to contribute to a healthier planet through innovative solutions for disease prevention and management. As a Venture Capital analyst, it is essential to track Zendal's evolution within the industry and monitor any potential investment opportunities that may arise in the future.